OPUS at UTS: Search - Open Publications of UTS Scholars

Search

Current filters:

Add Filter:

Results

Customise results display

Sort items by

In order

Results/Page

Authors/record

Item hits:

Issue Date	Title	Author(s)
2019-10-01	The Impact of Provision of Professional Language Interpretation on Length of Stay and Readmission Rates in an Acute Care Hospital Setting	Abbato, S; Greer, R; Ryan, J; Vayne-Bossert, P; Good, P
2019-12-06	Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: A double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)	Good, P; Haywood, A; Gogna, G; Martin, J; Yates, P; Greer, R; Hardy, J
2017-01	Rates and Predictors of Professional Interpreting Provision for Patients With Limited English Proficiency in the Emergency Department and Inpatient Ward.	Ryan, J; Abbato, S; Greer, R; Vayne-Bossert, P; Good, P
2023-03-01	Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD).	Hardy, J; Greer, R; Huggett, G; Kearney, A; Gurgenci, T; Good, P
2020-07-06	Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).	Hardy, J; Haywood, A; Gogna, G; Martin, J; Yates, P; Greer, R; Good, P
2023-10-14	Exploring potential anti-inflammatory effects of medicinal cannabis.	Gurgenci, T; Kijanka, G; Greer, R; Huggett, G; Good, P; Moniruzzaman, M; Hardy, J
2024-05-30	Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial.	Gurgenci, T; Hardy, J; Huggett, G; Foster, K; Pelecanos, A; Greer, R; Philip, J; Haywood, A; Mendis, R; Yates, P; Good, P
2024-05-01	Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial.	Gurgenci, T; Hardy, J; Huggett, G; Foster, K; Pelecanos, A; Greer, R; Philip, J; Haywood, A; Mendis, R; Yates, P; Good, P

Results 1-8 of 8 (Search time: 0.012 seconds).

previous
1
next